- Headquarters
- Austin (but entirely remote!)
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- faeththerapeutics.com
- Total Funding
- $92.0M
- Last Round
- $25.0M Series BOct 2025
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 7 investors for this company. The full record is or through the API.
About
Faeth Therapeutics (NASDAQ: FTH) is a clinical-stage oncology company pioneering multi-node inhibition of the PAM (PI3K/AKT/mTOR) pathway — the most frequently altered oncogenic pathway in cancer. Co-founded in 2019 by Anand Parikh and Oliver Maddocks, PhD, alongside world-leading cancer biologists including Dr. Lewis Cantley (discoverer of the PI3K pathway), Faeth was built on the core conviction that simultaneously suppressing multiple nodes of a biological pathway produces deeper, more durable tumor suppression than targeting a single node alone. The company's lead program, PIKTOR — a combination of serabelisib (PI3K-alpha inhibitor) and sapanisertib (mTORC1/2 inhibitor) — targets three PAM pathway nodes simultaneously. In February 2026, Faeth merged with Sensei Biotherapeutics in a transaction that included a concurrent $200 million private placement, with PIKTOR advancing as the combined publicly-traded company's lead clinical program.
Summary
It lists 11–50 employees. It has raised $92.0M in total across 3 rounds, most recently a $25.0M Series B round in Oct 2025. Investors include S2G Ventures, Khosla Ventures and Future Ventures.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2025
Sign up to see all 3 events
Funding: Seed through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Novel bicyclic peptides and drug conjugates for cancer
China's leading blood products manufacturer
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/faeth-therapeutics"><img src="https://indexed.vc/api/badge/company/faeth-therapeutics" alt="Faeth Therapeutics on Indexed.vc" width="260" height="76" /></a>